WINDTREE THERAPEUTICS NEW (WINT) Stock Price, Quote & AI Analysis
Live WINT stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for WINDTREE THERAPEUTICS NEW.
TradeVae provides AI-driven analysis and real-time market intelligence for WINDTREE THERAPEUTICS NEW (WINT), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
WINDTREE THERAPEUTICS NEW's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
WINDTREE THERAPEUTICS NEW Overview
Company information
Company Overview
Windtree Therapeutics, Inc. engages in the manufacture and development of products for infants and respiratory diseases. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA. WINT is listed on the OTCQB market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
WINDTREE THERAPEUTICS NEW Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...